Paper40520195
D-cycloserine effects on COPD and depression in a murine experimental model.
Heresco-Levy U and 6 others. Front Pharmacol, 2025. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. D-cycloserine effects on COPD and depression in a murine experimental model. Papers, record 40520195. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40520195
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References69
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24718106 | Efficacy of lovastatin on learning and memory deficits caused by chronic intermittent hypoxia-hypercapnia: through regulation of NR2B-containing NMDA receptor-ERK pathway. | PLoS One | 2014 | https://conductscience.org/library/papers/24718106 | PubMed |
| 2 | 21601717 | Prevalence of depressive symptoms in patients with chronic obstructive pulmonary disease: a systematic review, meta-analysis and meta-regression. | Gen Hosp Psychiatry | 2011 | https://conductscience.org/library/papers/21601717 | PubMed |
| 3 | 19959763 | Assessment of air space size characteristics by intercept (chord) measurement: an accurate and efficient stereological approach. | J Appl Physiol (1985) | 2010 | https://conductscience.org/library/papers/19959763 | PubMed |
| 4 | 27934938 | Changes in hippocampal AMPA receptors and cognitive impairments in chronic ketamine addiction models: another understanding of ketamine CNS toxicity. | Sci Rep | 2016 | https://conductscience.org/library/papers/27934938 | PubMed |
| 5 | 25495517 | The potential of targeting NMDA receptors outside the CNS. | Expert Opin Ther Targets | 2015 | https://conductscience.org/library/papers/25495517 | PubMed |
| 6 | 29946006 | Serotonergic antidepressant use and morbidity and mortality among older adults with COPD. | Eur Respir J | 2018 | https://conductscience.org/library/papers/29946006 | PubMed |
| 7 | 26836938 | Long-term Course of Depression Trajectories in Patients With COPD: A 3-Year Follow-up Analysis of the Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints Cohort. | Chest | 2016 | https://conductscience.org/library/papers/26836938 | PubMed |
| 8 | 31519879 | Comparative fitness analysis of D-cycloserine resistant mutants reveals both fitness-neutral and high-fitness cost genotypes. | Nat Commun | 2019 | https://conductscience.org/library/papers/31519879 | PubMed |
| 9 | 13637281 | Cyloserine as an antidepressant agent. | Am J Psychiatry | 1959 | https://conductscience.org/library/papers/13637281 | PubMed |
| 10 | 9860805 | Glycine and N-methyl-D-aspartate receptors: physiological significance and possible therapeutic applications. | Pharmacol Rev | 1998 | https://conductscience.org/library/papers/9860805 | PubMed |
| 11 | 36572534 | Brain activity measured by functional brain imaging predicts breathlessness improvement during pulmonary rehabilitation. | Thorax | 2023 | https://conductscience.org/library/papers/36572534 | PubMed |
| 12 | 19837828 | N-methyl-D-aspartate glutamate receptor blockade attenuates lung injury associated with experimental sepsis. | Chest | 2010 | https://conductscience.org/library/papers/19837828 | PubMed |
| 13 | 27629368 | Inflammation, Glutamate, and Glia: A Trio of Trouble in Mood Disorders. | Neuropsychopharmacology | 2017 | https://conductscience.org/library/papers/27629368 | PubMed |
| 14 | 15893822 | Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test. | Neurosci Biobehav Rev | 2005 | https://conductscience.org/library/papers/15893822 | PubMed |
| 15 | 38273271 | Estimating the global prevalence of chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis. | BMC Public Health | 2024 | https://conductscience.org/library/papers/38273271 | PubMed |
| 16 | 10889461 | NMDA receptor activation: critical role in oxidant tissue injury. | Free Radic Biol Med | 2000 | https://conductscience.org/library/papers/10889461 | PubMed |
| 17 | 28733898 | D-Cycloserine Ameliorates Autism-Like Deficits by Removing GluA2-Containing AMPA Receptors in a Valproic Acid-Induced Rat Model. | Mol Neurobiol | 2018 | https://conductscience.org/library/papers/28733898 | PubMed |
| 18 | 29465478 | Glutamatergic Modulators in Depression. | Harv Rev Psychiatry | 2018 | https://conductscience.org/library/papers/29465478 | PubMed |
| 19 | 33859248 | Functional NMDA receptors are expressed by human pulmonary artery smooth muscle cells. | Sci Rep | 2021 | https://conductscience.org/library/papers/33859248 | PubMed |
| 20 | 26232300 | Experimental progressive emphysema in BALB/cJ mice as a model for chronic alveolar destruction in humans. | Am J Physiol Lung Cell Mol Physiol | 2015 | https://conductscience.org/library/papers/26232300 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42251640 | Mechanism-Based Polypharmacy as a Repurposing Strategy: The Case of D-Cycloserine and Lurasidone. | Clin Transl Sci | 2026 | https://conductscience.org/library/papers/42251640 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40520195
GET https://conductscience.org/api/papers/v1/40520195/references?page=2